Go back to News
NEWS
IAM Patent 1000 Annual Ranking
24 of October, 2024
Recognition in the Silver category of the IAM Patent 1000 awards
The Firm has been awarded ‘Silver’ in the Patent Litigation category according to the annual ranking of the IAM Patent 1000 directory.
In addition, Jesús Muñoz-Delgado stands out in the ‘Gold’ category as a ‘Global Leader’, for his specialisation in Life Sciences, and specifically in patent matters in the biotechnology sector. Recognised for his strategic advice, he is involved in pan-European disputes and handles complex patent litigation with great skill.
To be included in IAM Global Leaders, practitioners must be ranked in the Golden category of the IAM Patent 1000, the annual benchmark directory that highlights the top law firms and specialists in the world’s most relevant patent jurisdictions.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
10 Jun, 2025 
PUBLICATION
One week ago
Limits of the Unified Patent Court's long arm with regard to Spain (IV): the recognition and enforcement of court decisions
The Unified Patent Court has jurisdiction, in certain cases and within the limits set by the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not party to the Agreement on a Unified Patent Court. Such decisions may be recognised and enforced in those other countries, but there are cases in which such recognition and enforcement will not be appropriate.
One week ago 
PUBLICATION
12 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (III): applicable law
The Unified Patent Court has jurisdiction, in certain cases and within the limits laid down in the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not contracting parties to the Agreement on a Unified Patent Court. However, this does not mean that, when hearing such actions, the Court may apply the same rules as if the actions related to a unitary patent.
12 Jun, 2025
PUBLICATION
11 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (II): the controversial judgment of the Court of Justice in the BSH/Electrolux case
This document sets out and criticises the doctrine established by the CJEU in its Judgment of 25 February 2025, C-339/22, BSH/Electrolux, ECLI:EU:C:2025:108. Although the dispute underlying the judgment was not brought before the UPC, the interpretation of the CJEU in the BSH/Electrolux judgment is equally applicable, since said court is equivalent to the national courts of the contracting states party to the UPC Agreement.
11 Jun, 2025
PUBLICATION
10 Jun, 2025
Limits of the Unified Patent Court's long arm with regard to Spain (I): international jurisdiction
Ever since coming into operation, there has been a tendency on the part of the Unified Patent Court to extend its jurisdiction to include patents that produce effects in States that are not party to the Agreement on a Unified Patent Court (the ‘UPC Agreement’ or ‘Agreement’), as is the case of the Kingdom of Spain. This phenomenon is known in specialised circles as the court's ‘long arm’. However, although in certain cases the Unified Patent Court (the ‘UPC’ or ‘Court’) does indeed have such jurisdiction, this is only possible within strict limits, limits that do not seem to be taken into consideration in a consistent manner.
10 Jun, 2025
PUBLICATION
16 Apr, 2025
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
16 Apr, 2025
PUBLICATION
27 Mar, 2025
The notion of ‘pharmacological action’ in the legal concept of medicinal product
A look at the judgment of the Court of Justice in Case C-589/23, Cassella-med and MCM Klosterfrau, ECLI:EU:C:2025:173.
27 Mar, 2025
PUBLICATION
20 Mar, 2025
Use of environmental claims in advertising: the Iberdrola v. Repsol case
Santander Companies Court No. 2 Judgment no. 12/2025 of 21 February, which is not conclusive, is analysed.
20 Mar, 2025
PUBLICATION
10 Mar, 2025
Pharma & Healthcare No. 42
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
10 Mar, 2025
PUBLICATION
07 Feb, 2025
New obligation to make health data available to third parties: issues with protected data
This paper explores the new obligation to make health data available to third parties in light of the Regulation of the European Parliament and of the Council on the European Health Data Space.
07 Feb, 2025